Komori
Samco (6387) · InitiativeRestated

Continuation of Research and Development Activities

First written in FY2016-Q3. 27 of 33 entries say "Restated". Latest entry: FY2026-H1.

33entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2018-Q1 – FY2022-Q3RestatedFY2024-Q1 – FY2025-H12016: 320162017: 320172018: 420182019: 420192020: 420202021: 320212022: 320222023: 420232024: 220242025: 220252026: 1
Same theme, other companies
Continuation of R&D activities with no change in statusA theme 192 companies write about · 0 as a headwind · 181 as a tailwind

97 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 192 companies compared. The sentences above are computed from all 192.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1RestatedAnnual report

    「Research and development expenses for the interim accounting period amounted to ¥180 million. There were no material changes to the Company's research and development activities during the interim accounting period.」

    The Company recorded ¥180 million in research and development expenses and reaffirmed that there were no material changes to its research and development activities.
  2. FY2025AdvancedAnnual report

    「The Advanced Technology Development Building was completed in September 2025. It will operate multiple project-based initiatives at the research and development center to invigorate equipment development, including improvements and enhancements to existing equipment, development of new products and demonstration experiments to support sales, with the aim of further strengthening the research and development structure. Research and development expenses for the fiscal year amounted to ¥302 million in connection with these activities.」

    The Advanced Technology Development Building was completed in September 2025 and is being operated as a research and development base for improving existing equipment, developing new products and conducting demonstration experiments, among other activities. Research and development expenses amounted to ¥302 million.
  3. FY2025-H1RestatedAnnual report

    「Research and development expenses for the interim accounting period amounted to ¥152 million. There were no material changes to the Company's research and development activities during the interim accounting period.」

    The Company reaffirmed that there were no material changes to its research and development activities and recorded ¥152 million in research and development expenses.
  4. FY2024-Q3RestatedAnnual report

    「Research and development expenses for the cumulative third quarter amounted to ¥196 million. There were no material changes to the Company's research and development activities during the cumulative third quarter.」

    The Company recorded ¥196 million in research and development expenses and reaffirmed that there were no material changes to its research and development activities.
  5. FY2024-Q2RestatedAnnual report

    「Research and development expenses for the cumulative second quarter amounted to ¥122 million. There were no material changes to the Company's research and development activities during the cumulative second quarter.」

    The Company recorded ¥122 million in research and development expenses and reaffirmed that there were no material changes to its research and development activities.
  6. FY2024-Q1RestatedAnnual report

    「Research and development expenses for the cumulative first quarter amounted to ¥62 million. There were no material changes to the Company's research and development activities during the cumulative first quarter.」

    The Company reaffirmed that there were no material changes to its research and development activities and recorded ¥62 million in research and development expenses.
  7. FY2023AdvancedAnnual report

    「Construction of an annex to the research and development center is under way, with completion scheduled for December 2024, to further strengthen the research and development structure.」

    As a measure to strengthen the research and development structure, construction of an annex to the research and development center is under way, with completion scheduled for December 2024.
  8. FY2023-Q3RestatedAnnual report

    「Research and development expenses for the cumulative third quarter amounted to ¥184 million. There were no material changes to the Company's research and development activities during the cumulative third quarter.」

    The Company recorded ¥184 million in research and development expenses and reaffirmed that there were no material changes to its research and development activities.
  9. FY2023-Q2RestatedAnnual report

    「Research and development expenses for the cumulative second quarter amounted to ¥128 million. There were no significant changes in the Company's research and development activities during the cumulative second quarter.」

    The disclosure records research and development expenses of ¥128 million and reconfirms that there were no significant changes in research and development activities.
  10. FY2023-Q1RestatedAnnual report

    「Research and development expenses for the cumulative first quarter amounted to ¥65 million. There were no significant changes in the Company's research and development activities during the cumulative first quarter.」

    The disclosure records research and development expenses of ¥65 million and reconfirms that there were no significant changes in research and development activities.
  11. FY2022AdvancedAnnual report

    「The Head Office Research and Development Center operates projects across multiple themes aimed at stimulating equipment development. Its activities include upgrading and improving existing equipment, developing new products, and conducting demonstration experiments to support sales. The Nanofilm Development Center, launched in March 2022, focuses on developing thin-film deposition equipment centered on ALD equipment, developing deposition process technologies primarily for nanoscale oxide and nitride films, conducting basic research on thin-film properties, and evaluating physical properties.」

    The Nanofilm Development Center was launched in March 2022, establishing specific research and development areas covering ALD equipment, nanofilm deposition processes, basic research, and physical-property evaluation. Research and development expenses amounted to ¥255 million.
  12. FY2022-Q3RestatedAnnual report

    「Research and development expenses for the cumulative third quarter amounted to ¥190 million. There were no significant changes in the Company's research and development activities during the cumulative third quarter.」

    The disclosure records research and development expenses of ¥190 million and reconfirms that there were no significant changes in research and development activities.
  13. FY2022-Q1RestatedAnnual report

    「Research and development expenses for the cumulative first quarter amounted to ¥71 million. There were no significant changes in the Company's research and development activities during the cumulative first quarter.」

    The disclosure records research and development expenses of ¥71 million and reconfirms that there were no significant changes in research and development activities.
  14. FY2021-Q3RestatedAnnual report

    「Research and development expenses for the cumulative third quarter amounted to ¥198 million. There were no significant changes in the Company's research and development activities during the cumulative third quarter.」

    The disclosure reconfirms that there were no significant changes in research and development activities and records research and development expenses of ¥198 million.
  15. FY2021-Q2RestatedAnnual report

    「Research and development expenses for the cumulative second quarter amounted to ¥135 million. There were no significant changes in the Company's research and development activities during the cumulative second quarter.」

    The disclosure records research and development expenses of ¥135 million and reconfirms that there were no significant changes in research and development activities.
  16. FY2021-Q1RestatedAnnual report

    「Research and development expenses for the cumulative first quarter amounted to ¥64 million. There were no significant changes in the Company's research and development activities during the cumulative first quarter.」

    The disclosure reconfirms that there were no significant changes in research and development activities and records research and development expenses of ¥64 million.
  17. FY2020RestatedAnnual report

    「The Head Office Research and Development Center operates projects across multiple themes aimed at stimulating equipment development. Its activities include upgrading and improving existing equipment, developing new products, and conducting demonstration experiments to support sales. The U.S. Optofilms Research Institute conducts basic research on new semiconductor materials. The company also actively conducts joint research with external parties and, where promising themes arise, conducts joint research with universities and other research institutions.」

    The company continues joint research with the Head Office Research and Development Center, the U.S. research institute, and universities and other institutions, as well as improvements to existing equipment, new product development, and demonstration experiments. Research and development expenses amounted to ¥205 million.
  18. FY2020-Q3RestatedAnnual report

    「Research and development expenses for the cumulative third quarter amounted to ¥149 million. There were no significant changes in the Company's research and development activities during the cumulative third quarter.」

    The disclosure records research and development expenses of ¥149 million and reconfirms that there were no significant changes in research and development activities.
  19. FY2020-Q2RestatedAnnual report

    「Research and development expenses for the cumulative second quarter amounted to ¥96 million. There were no significant changes in the Company's research and development activities during the cumulative second quarter.」

    The disclosure records research and development expenses of ¥96 million and reconfirms that there were no significant changes in research and development activities.
  20. FY2020-Q1RestatedAnnual report

    「Research and development expenses for the cumulative first quarter amounted to ¥48 million. There were no significant changes in the Company's research and development activities during the cumulative first quarter.」

    The disclosure records research and development expenses of ¥48 million and reconfirms that there were no significant changes in research and development activities.
  21. FY2019RestatedAnnual report

    「The Head Office Research and Development Center operates projects across multiple themes aimed at stimulating equipment development. Its activities include upgrading and improving existing equipment, developing new products, and conducting demonstration experiments to support sales. The U.S. Optofilms Research Institute conducts basic research on new semiconductor materials. The company also actively conducts joint research with external parties and, where promising themes arise, conducts joint research with universities and other research institutions.」

    The company continues research and development at its head office, U.S. research institute, and external research institutions, as well as improvements to existing equipment and new product development. Research and development expenses amounted to ¥170 million.
  22. FY2019-Q3RestatedAnnual report

    「Research and development expenses for the cumulative third quarter amounted to ¥129 million. There were no significant changes in the Company's research and development activities during the cumulative third quarter.」

    The disclosure records research and development expenses of ¥129 million and reconfirms that there were no significant changes in research and development activities.
  23. FY2019-Q2RestatedAnnual report

    「Research and development expenses for the cumulative second quarter amounted to ¥81 million. There were no significant changes in the Company's research and development activities during the cumulative second quarter.」

    The disclosure reconfirms that there were no significant changes in research and development activities and records research and development expenses of ¥81 million.
  24. FY2019-Q1RestatedAnnual report

    「Research and development expenses for the cumulative first quarter amounted to ¥43 million. There were no significant changes in the Company's research and development activities during the cumulative first quarter.」

    The disclosure reconfirms that there were no significant changes in research and development activities and records research and development expenses of ¥43 million.
  25. FY2018RestatedAnnual report

    「The Head Office Research and Development Center operates projects across multiple themes aimed at stimulating equipment development. Its activities include upgrading and improving existing equipment, developing new products, and conducting demonstration experiments to support sales. The U.S. Optofilms Research Institute conducts basic research on new semiconductor materials. The company also actively conducts joint research with external parties and, where promising themes arise, conducts joint research with universities and other research institutions.」

    The company continues research and development at its head office, U.S. research institute, and universities and other institutions, as well as improvements to existing equipment, new product development, and demonstration experiments. Research and development expenses amounted to ¥191 million.
  26. FY2018-Q3RestatedAnnual report

    「Research and development expenses for the cumulative third quarter amounted to ¥139 million. There were no significant changes in the Company's research and development activities during the cumulative third quarter.」

    The disclosure reconfirms that there were no significant changes in research and development activities and records research and development expenses of ¥139 million.
  27. FY2018-Q2RestatedAnnual report

    「Research and development expenses for the cumulative second quarter amounted to ¥90 million. There were no significant changes in the Company's research and development activities during the cumulative second quarter.」

    The disclosure reconfirms that there were no significant changes in research and development activities and records research and development expenses of ¥90 million.
  28. FY2018-Q1RestatedAnnual report

    「Research and development expenses for the cumulative first quarter amounted to ¥48 million. There were no significant changes in the Company's research and development activities during the cumulative first quarter.」

    The disclosure reconfirms that there were no significant changes in research and development activities and states research and development expenses of ¥48 million for the quarter.
  29. FY2017AdvancedAnnual report

    「The Head Office Research and Development Center operates projects across multiple themes aimed at stimulating equipment development. Its activities include upgrading and improving existing equipment, developing new products, and conducting demonstration experiments to support sales. In September 2016, it developed the Aqua Plasma equipment AQ-2000 and began selling it.」

    The disclosure describes the continuation of research and development activities and the specific achievement of developing and beginning sales of the Aqua Plasma equipment AQ-2000. Research and development expenses amounted to ¥182 million.
  30. FY2017-Q3RestatedAnnual report

    「Research and development expenses for the cumulative third quarter amounted to ¥132 million. There were no significant changes in the Company's research and development activities during the cumulative third quarter.」

    The disclosure records research and development expenses of ¥132 million and reconfirms that there were no significant changes in research and development activities.
  31. FY2017-Q1RestatedAnnual report

    「Research and development expenses for the cumulative first quarter amounted to ¥41 million. There were no significant changes in the Company's research and development activities during the cumulative first quarter.」

    The disclosure reconfirms that there were no significant changes in research and development activities and states research and development expenses of ¥41 million for the quarter.
  32. FY2016AdvancedAnnual report

    「The Head Office Research and Development Center operates projects across multiple themes aimed at stimulating equipment development. Its activities include upgrading and improving existing equipment, developing new products, and conducting demonstration experiments to support sales.」

    The disclosure describes specific research and development activities, including projects across multiple themes, improvements to existing equipment, new product development, and demonstration experiments. Research and development expenses amounted to ¥200 million.
  33. FY2016-Q3First statedAnnual report

    「Research and development expenses for the cumulative third quarter amounted to ¥156 million. There were no significant changes in the Company's research and development activities during the cumulative third quarter.」

    The disclosure states research and development expenses for the cumulative third quarter and that there were no significant changes in research and development activities.
Moved together

"Performance growth driven by the electronic components segment" moved the same way as this thread, in the same document, in 4 of its 33 moves.

444333★123456
  1. ★This thread
  2. 1Performance growth driven by the electronic components segment4×
  3. 2Expansion of Etching Equipment into High-Frequency Filter Applications4×
  4. 3Dividend of ¥18 per share4×
  5. 4Broad demand for cleaning equipment and repeat sales3×
  6. 5Sluggish domestic sales of CVD equipment3×
  7. 6Maintenance, Parts and Modification Demand for Existing Equipment3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Samco yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Continuation of Research and Development Activities | SAMCO INC. (6387) | Komori